Overview

Trial To Evaluate RPh201 In Treatment Of Partial Thickness Burn

Status:
Withdrawn
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The objective of this Trial is to evaluate the performance of RPh201 as a treatment for the healing of partial thickness burns. It is further postulated that deep second degree lesions will benefit from the RPh201 treatment promoting granulation and epithelialization as well as wound closure.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Regenera Pharma Ltd